1. Home
  2. ADVM vs UFI Comparison

ADVM vs UFI Comparison

Compare ADVM & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • UFI
  • Stock Information
  • Founded
  • ADVM 2006
  • UFI 1969
  • Country
  • ADVM United States
  • UFI United States
  • Employees
  • ADVM N/A
  • UFI N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • UFI Textiles
  • Sector
  • ADVM Health Care
  • UFI Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • UFI Nasdaq
  • Market Cap
  • ADVM 94.6M
  • UFI 84.6M
  • IPO Year
  • ADVM 2014
  • UFI N/A
  • Fundamental
  • Price
  • ADVM $4.31
  • UFI $3.84
  • Analyst Decision
  • ADVM Buy
  • UFI
  • Analyst Count
  • ADVM 5
  • UFI 0
  • Target Price
  • ADVM $16.60
  • UFI N/A
  • AVG Volume (30 Days)
  • ADVM 1.0M
  • UFI 47.7K
  • Earning Date
  • ADVM 11-07-2025
  • UFI 11-04-2025
  • Dividend Yield
  • ADVM N/A
  • UFI N/A
  • EPS Growth
  • ADVM N/A
  • UFI N/A
  • EPS
  • ADVM N/A
  • UFI N/A
  • Revenue
  • ADVM $1,000,000.00
  • UFI $559,646,000.00
  • Revenue This Year
  • ADVM $1,191.10
  • UFI $7.18
  • Revenue Next Year
  • ADVM N/A
  • UFI $6.72
  • P/E Ratio
  • ADVM N/A
  • UFI N/A
  • Revenue Growth
  • ADVM N/A
  • UFI N/A
  • 52 Week Low
  • ADVM $1.78
  • UFI $3.83
  • 52 Week High
  • ADVM $8.18
  • UFI $6.49
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 50.55
  • UFI 24.06
  • Support Level
  • ADVM $4.18
  • UFI $4.33
  • Resistance Level
  • ADVM $4.37
  • UFI $4.69
  • Average True Range (ATR)
  • ADVM 0.20
  • UFI 0.20
  • MACD
  • ADVM -0.03
  • UFI -0.05
  • Stochastic Oscillator
  • ADVM 51.58
  • UFI 1.17

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: